{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:47:33Z","timestamp":1789778853102,"version":"4.0.1"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0225631","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T14:48:24Z","timestamp":1574347704000},"page":"e0225631","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Genotyping and outcomes of presumptive second line ART failure cases switched to third line or maintained on second line ART in Mumbai, India"],"prefix":"10.1371","volume":"14","author":[{"given":"Naresh","family":"Gill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6277-8713","authenticated-orcid":true,"given":"Rafael","family":"Van den Bergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khine","family":"Wut Yee Kyaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1561-3857","authenticated-orcid":true,"given":"Chinmay","family":"Laxmeshwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrinalini","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarthak","family":"Rastogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Arago Galindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Homa","family":"Mansoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stobdan","family":"Kalon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Isaakidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,11,21]]},"reference":[{"key":"pone.0225631.ref001","unstructured":"UNAIDS. Global HIV & AIDS statistics\u20142018 fact sheet | UNAIDS [Internet]. [cited 14 Dec 2018]. Available: http:\/\/www.unaids.org\/en\/resources\/fact-sheet"},{"key":"pone.0225631.ref002","unstructured":"United Nations. Sustainable Development Goals [Internet]. 2015."},{"key":"pone.0225631.ref003","unstructured":"UNAIDS. 90-90-90 An ambitious treatment target to help end the AIDS epidemic [Internet]. 2014. Available: http:\/\/www.unaids.org\/Sites\/Default\/Files\/Media_Asset\/90-90-90_En_0.Pdf"},{"key":"pone.0225631.ref004","author":"World Health Organization","year":"2015","journal-title":"Policy Brief: Consolidated guidelines on the use of Antiretroviral Drugs for treating and preventing HIV infection: What\u2019s New"},{"key":"pone.0225631.ref005","doi-asserted-by":"crossref","first-page":"e414","DOI":"10.1016\/S2352-3018(15)00180-0","article-title":"HIV viral load messages should go viral in India","volume":"2","author":"P Isaakidis","year":"2015","journal-title":"Lancet HIV"},{"key":"pone.0225631.ref006","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/cid\/ciw001","article-title":"Scale-up of Routine Viral Load Testing in Resource-Poor Settings: Current and Future Implementation Challenges","volume":"62","author":"T Roberts","year":"2016","journal-title":"Clin Infect Dis"},{"key":"pone.0225631.ref007","author":"World Health Organization","year":"2014","journal-title":"The Availability and use of HIV diagnostics: A 2012\u20132013 who survey in Low and middle income countries"},{"key":"pone.0225631.ref008","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/COH.0000000000000004","article-title":"Beyond first-line HIV treatment regimens","volume":"8","author":"N Kumarasamy","year":"2013","journal-title":"Curr Opin HIV AIDS"},{"key":"pone.0225631.ref009","first-page":"447","article-title":"Study of the impact of HIV genotypic drug resistance testing on therapy efficacy","volume":"63","author":"K. Van Vaerenbergh","year":"2001","journal-title":"Verh K Acad Geneeskd Belg"},{"key":"pone.0225631.ref010","unstructured":"National AIDS Control Organisation. National Strategic Plan for HIV\/AIDS and STI,2017. New Delhi; 2017."},{"key":"pone.0225631.ref011","unstructured":"Department of Health & Family Welfare. NACO Annual Report 2016\u201317. New Delhi; 2017."},{"key":"pone.0225631.ref012","unstructured":"UNAIDS. South Africa | UNAIDS [Internet]."},{"key":"pone.0225631.ref013","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/apc.2006.0045","article-title":"Knowledge, Attitudes, And Practices of Antiretroviral Therapy among HIV-Infected Adults Attending Private And Public Clinics in India","volume":"21","author":"SR Ramchandani","year":"2007","journal-title":"AIDS Patient Care STDS"},{"key":"pone.0225631.ref014","unstructured":"MINISTRY OF HEALTH AND FAMILY WELFARE. Report of the National Commission on Macroeconomics and Health. 2005."},{"key":"pone.0225631.ref015","unstructured":"World Health Organisation. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach [Internet]. 2013. 978 92 4 150572 7"},{"key":"pone.0225631.ref016","unstructured":"Ministry of Health and Family Welfare. Guidelines for provision of third line ART inder National AIDS Control Programme. New Delhi; 2016. p. 2."},{"key":"pone.0225631.ref017","unstructured":"Mumbai District AIDS Control Society. Care & Support and Treatment (CST) [Internet]."},{"key":"pone.0225631.ref018","unstructured":"Maharashtra State AIDS Control Society. ART [Internet]."},{"key":"pone.0225631.ref019","unstructured":"National AIDS Control Organisation. Training modules for Medical Officers on HIV care and Treatment. New Delhi; 2007."},{"key":"pone.0225631.ref020","unstructured":"World Health Organization. HIV TREATMENT AND CARE. 2015."},{"key":"pone.0225631.ref021","volume-title":"Antiretroviral therapy for HIV Infection in adults and adolescents","author":"World Health Organization","year":"2010"},{"key":"pone.0225631.ref022","volume-title":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach","author":"World Health Organization","year":"2016"},{"key":"pone.0225631.ref023","author":"World Health Organization","year":"2016","journal-title":"Consolidated Guidelines on HIV prevention, diagnosis, treatment and care for key populations-2016 update"},{"key":"pone.0225631.ref024","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1752-1505-4-12","article-title":"Provision of antiretroviral treatment in conflict settings: the experience of M\u00e9decins Sans Fronti\u00e8res","volume":"4","author":"DP O\u2019Brien","year":"2010","journal-title":"Confl Health"},{"key":"pone.0225631.ref025","unstructured":"STANFORD HIV DRUG RESISTANCE DATABASE Major HIV-1 Drug Resistance Mutations Major Non-Nucleoside RT Inhibitor (NNRTI) Resistance Mutations. 2017."},{"key":"pone.0225631.ref026","first-page":"1","article-title":"Second-line failure and first experience with third-line antiretroviral therapy in Mumbai, India","volume":"1","author":"S Khan","year":"2014","journal-title":"Glob Heal"},{"key":"pone.0225631.ref027","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1097\/QAI.0b013e3182a6104a","article-title":"Short-term effectiveness and safety of third-line antiretroviral regimens among patients in Western India","volume":"65","author":"SN Pujari","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"pone.0225631.ref028","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/cid\/cir967","article-title":"Viremia and HIV-1 drug resistance mutations among patients receiving second-line highly active antiretroviral therapy in Chennai, Southern India","volume":"54","author":"S Saravanan","year":"2012","journal-title":"Clin Infect Dis"},{"key":"pone.0225631.ref029","author":"AF Schoffelen","journal-title":"Sustained Virological Response on Second-Line Antiretroviral Therapy following Virological Failure in HIV-Infected Patients in Rural South Africa"},{"key":"pone.0225631.ref030","doi-asserted-by":"crossref","first-page":"29943","DOI":"10.3402\/gha.v9.29943","article-title":"Retention in care among HIV-positive patients initiating second-line antiretroviral therapy: a retrospective study from an Ethiopian public hospital clinic","volume":"9","author":"S Wilhelmson","year":"2016","journal-title":"Glob Health Action"},{"key":"pone.0225631.ref031","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/tmi.12741","article-title":"Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa","volume":"21","author":"MP Fox","year":"2016","journal-title":"Trop Med Int Heal"},{"key":"pone.0225631.ref032","doi-asserted-by":"crossref","first-page":"e0178942","DOI":"10.1371\/journal.pone.0178942","article-title":"Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy","volume":"12","author":"J Sv\u00e4rd","year":"2017","journal-title":"PLoS One"},{"key":"pone.0225631.ref033","article-title":"One-, Two-, and Three-Class Resistance among HIV-Infected Patients on Antiretroviral Therapy in Private Care Clinics: Mumbai, India","author":"A Gupta","year":"2010","journal-title":"AIDS Res Hum Retroviruses"},{"key":"pone.0225631.ref034","doi-asserted-by":"crossref","first-page":"532","DOI":"10.2174\/157016212802429785","article-title":"Prevalence of HIV drug resistance mutation in the northern Indian population after failure of the first line antiretroviral therapy","volume":"10","author":"S Sinha","year":"2012","journal-title":"Curr HIV Res"},{"key":"pone.0225631.ref035","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/infdis\/jir025","article-title":"HIV-1 integrase inhibitor resistance and its clinical implications","volume":"203","author":"J-L Blanco","year":"2011","journal-title":"J Infect Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0225631","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T14:48:39Z","timestamp":1574347719000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0225631"}},"subtitle":[],"editor":[{"given":"Marcel","family":"Yotebieng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,11,21]]},"references-count":35,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0225631","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,21]]}}}